In the present paper, we report the identification of a new gene encoding a transmembrane protein of 520 amino acids, showing 22 % amino acid identity with the extracellular domain of the interleukin (IL)-20 receptor. This gene, termed likely interleukin or cytokine receptor-2 (LICR2), is located on chromosome 1, at 25 kb from the IL22R (IL-22 receptor) gene, and is constitutively expressed in most tissues. A chimaeric receptor, consisting of the extracellular domain of the IL-10 receptorα chain and the intracellular domain of LICR2, activated signal transducer and
INTRODUCTION
Type II cytokine receptors include receptors for type I and II interferons (IFNs), and for interleukin (IL)-10-related cytokines [1] . These transmembrane proteins are almost exclusively related by their extracellular part, which consists of tandem fibronectin type III domains, whereas the cytoplasmic domain is associated with a tyrosine kinase of the Janus kinase (JAK) family. The type II cytokine receptor (R) family consists of 11 members, including two pairs of two receptor subunits for both type I (IFNα, IFNβ, IFNω and IFNτ) and type II (IFNγ) interferons, and IL-10Rα, IL-10Rβ, IL-20Rα, IL-20Rβ, IL-22R, IL-22 binding protein (IL-22BP) and tissue factor (TF) [1] [2] [3] [4] . Four of the corresponding genes, IFNAR1, IFNAR2, IL10R2 and IFNGR2 are clustered on human chromosome 21 ; IL22BP, IFNGR1 and IL20R1 genes map to chromosome 6 ; TF and IL22R genes are located on chromosome 1, IL20R2 is on chromosome 3 and IL10R1 is on chromosome 11.
The IL-10-related cytokine family consists of six members, including IL-10, for which biological activities and receptor usage have been extensively described [5] . More recently, a series of new cytokines, structurally related to IL-10, have emerged. This family includes melanoma-differentiation-associated gene-7 (' mda-7 ' or IL-24), IL-19, IL-20, IL-10-related T-cell-derived inducible factor (IL-TIF or IL-22) and IL-26 (or AK155) [6] [7] [8] . Although none of these IL-10-related cytokines mimics IL-10 activities, they are likely to be involved in inflammatory processes as well. IL-24, IL-19 and IL-20 form a subfamily, based on conserved amino acid sequences, and on the use of shared receptor complexes [9, 10] . Functional studies have stressed the potential tumour-suppressing activity of IL-24 [11] , while IL-20
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activator of transcription (STAT)1, STAT2, STAT3 and STAT5 upon IL-10 stimulation, in a Janus kinase 1-dependent manner. In contrast, none of the IL-10-related cytokines described so far could activate LICR2-transfected cells, suggesting that LICR2 is a signalling receptor for a new cytokine of the IL-10 family.
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and IL-19 seem to be involved in skin abnormalities [2, 12] . IL-22 binds to a complex formed by IL-22R and IL-10Rβ [3] , and was shown to up-regulate acute-phase-reactant production by liver and pancreatic cells [13, 14] . Finally, for IL-26 (AK155), originally described as encoded by a gene induced upon T-cell transformation by herpesvirus saimiri [15] , functional data are still lacking to determine its biological activities and receptor usage.
In order to complete the picture of the cytokine receptor II family, we screened genomic DNA databases for similarity with the extracellular domains of type II cytokine receptors. In the present paper, we describe a new member of this family and show that the cytoplasmic domain of this new receptor is able to activate signal transducer and activator of transcription (STAT) factors and that this activation is JAK1-dependent.
EXPERIMENTAL DNA sequence similarity searches
A search for similarity was performed with the protein sequence of IL-22BP using the TBLASTN software to screen the human genome databases. Regions presenting a putative similarity were analysed further by the NIX analysis program (http:\\www. hgmp.mrc.ac.uk\Registered\Webapp\nix\) developed by the U.K. Human Genome Mapping Project Resource Centre. A phylogenetic tree was generated by multiple alignment of the extracellular domains of the class II cytokine receptors using the ClustalX Multiple Sequence Alignment program [16] 
Likely interleukin or cytokine receptor-2 (LICR2) and chimaeric IL-10R-LICR2 expression constructs
Total RNA was isolated from various organs using the TRIzol2 (Roche) method according to the manufacturer's recommendations. Reverse transcription was performed on 5 µg of total RNA with an oligo(dT) primer. cDNA corresponding to 5 ng of total RNA was amplified for 33 cycles by PCR with specific primers for LICR2 as follows : sense 5h-GGGAACCAAGGAGCTGC-TATG-3h and antisense 5h-TGGCACTGAGGCAGTGGTGTT3h. These primers are located on exons 3 and 5 of LICR2 respectively. The annealing temperature was 56 mC. The PCR products were analysed in ethidium-bromide-stained 1 % (w\v) agarose gels. Alternatively, another PCR was performed with primers located on exons 5 and 7 of LICR2 as follows : sense 5h-ACCTGCTTCTTGCTGGAGGTC-3h and antisense 5h-AAGCTGACGCCATCTTCTGTG-3h. The full-length open reading frame (ORF) was amplified by reverse transcriptase (RT)-PCR in two steps. The 5h region was amplified from colon oligo(dT)-primed cDNA using sense primer 5h-AAGGCCATG-GCGGGGCCCGA-3h and antisense primer 5h-CAGAAGGT-CAGTGTCTGAAG-3h, located on exons 1 and 7 respectively, generating the expected fragment of 1424 nucleotides. The 3h region of the ORF was amplified from a HepG2 cell line using oligonucleotide primers : sense 5h-ACCTGCTTCTTGCTGGA-GGTC-3h and antisense 5h-CATCAGATTCGGTGGGATGTC3h, which amplified a fragment of 951 nucleotides from exons 5 to 7 (overlapping with the 5h fragment). Both fragments were cloned and digested at the XhoI site located at position 916 from the start codon and present on both amplified fragments. The full-length ORF was next reconstituted by ligation of the two fragments into a pCEP4 plasmid.
The construct encoding a chimaeric protein with the extracellular part of IL-10R and the intracellular part of LICR2 was generated as follows. The extracellular part of mouse IL-10Rα was amplified using a mutated sense primer that introduced a NcoI site 5h-GCTCCATGGGACGATGCCGCTGTG-3h and a mutated antisense primer with an SspI site 5h-GTGAAATA-TTGCTCCGTCGT-3h. Human LICR2 transmembrane and intracellular domains were amplified from the pCEP4-LICR2 construct using a mutated sense primer that introduced an SspI site 5h-GAAGAATATTGGGCTTTCCTGGTGCTG-3h and an antisense primer located on pCEP4 plasmid. After amplification, both PCR products were digested and cloned into pEF\myc\cyto plasmid (Invitrogen, Groningen, The Netherlands) under the control of the elongation factor-1 promoter. The clones obtained were sequenced with an automated fluorescence-based system (Applied Biosystems 310) using the ABI Prism2 BigDye TM Terminator Cycle Sequencing Ready Reaction Kit (PE Biosystems, Foster City, CA).
Western blots and luciferase assay
Functional STAT activation was assessed by measuring luciferase production by cells transfected with the pGRR5 construct (provided by Dr P. Brennan, University of Wales College of Medicine, Cardiff, Wales, U.K.). This construct contains five copies of the STAT-binding site of the FcγRI gene inserted upstream from a luciferase gene controlled by the thymidine kinase (TK) promoter. As an internal control, we used the pRL-TK vector (Promega, Madison, WI) containing the Renilla luciferase gene under the control of the TK promoter.
A sample of 10' HT-29 cells were transiently transfected by electroporation (250 V, 1200 µF and 192 Ω) with 15 µg of chimaeric IL-10R-LICR2 construct, 15 µg of pGRR5 and 1 µg of pRL-TK. Cells were then seeded in 12-well plates (Nunc, Rochester, NY) at 8i10& cells\well. After 5 h, cells were stimulated for 2 h with or without IL-10 or IL-22. Luciferase assays were performed using the dual luciferase reporter assay kit (Promega, Madison, WI).
Transient transfections of 2C4, U4C, and γ2A fibrosarcoma cells [17, 18] were carried out as described in [19] . Briefly, cells were seeded in 24-well plates at 2i10& cells\well 1 day before transfection. Transfection was carried out using the -AMINE TM method (Invitrogen, Groningen, The Netherlands), according to the manufacturer's recommendations, with 500 ng of IL-10R-LICR2 chimaeric cDNA, 40 ng of pRK5-JAK1, pRK5-JAK2, 100 ng of pGRR5, and 100 ng of pRL-TK. At 5 h after transfection, cells were stimulated with control medium or human IL-10 (10 ng\ml) for 4 h. Luciferase assays were performed using the dual luciferase reporter assay kit.
IL-10R-LICR2 chimaeric receptor cDNA was transiently transfected by electroporation (250 V, 1200 µF and 192 Ω) in H4IIE cells. Transfected cells were seeded in six-well plates for 5 h, before stimulation for 15 min with or without IL-10 or IL-22. Cells were then lysed in 500 µl of Laemmli buffer (Bio-Rad) and boiled for 3 min before loading on pre-cast Novex (Carlsbad, CA) SDS\polyacrylamide gels (8 or 14 %) and electrophoretic transfer to nitrocellulose membranes (Hybond C ; Amersham Biosciences). Membranes were blocked in 5 % (w\v) non-fat dry milk, washed, and probed using antibodies specific for phosphorylated STAT2-Y-689 (Upstate Biotechnology, Lake Placid, NY), STAT1-Y701, STAT3-Y705, STAT5-Y694 and extracellular-signal-regulated kinase (ERK)1\2 (Cell Signaling, Beverly, MA). Blots were reprobed with anti-( β-actin) antibodies (Sigma, Bornem, Belgium) as a control. A SuperSignal West Pico detection kit (Pierce, Rockford, IL) was used for detection.
RESULTS

Characterization of a new gene of the class II cytokine receptor family
In order to identify putative new members of the class II cytokine receptor family, which includes receptors for IFNs and IL-10, we screened human genome databases with the IL-22BP protein sequence. One short region of homology was found, at about 25 kb from the IL22R gene, showing 38 % amino acid identity with residues 68 to 113 from IL-22BP, suggesting the presence of a new member of this gene family. This genome sequence was further analysed using the NIX analysis program. This software predicted seven exons stretching over approx. 30 kb. The genomic organization is shown in Figure 1 and the intron\exon junctions were confirmed by a series of RT-PCRs using oligonucleotides located in the predicted exons. The gene, which was provisionally designated LICR2 (for likely cytokine or interleukin receptor-2), is located together with IL22R on chromosome 1, in the same orientation as IL22R ( Figure 1A) .
A cDNA fragment of 1600 nucleotides, including a 1560 bp ORF, was amplified by RT-PCR from human colon and hepatoma mRNA. The predicted LICR2 protein contains 520 amino acids (EMBL\GenBank2 accession number AJ534330), including a stretch of hydrophobic residues at the N-terminus, compatible with a signal peptide, and an internal hydrophobic segment, encoded by exon 6, and which might correspond to the transmembrane domain. The extracellular domain, encoded by exons 2 to 5, showed between 18 and 23 % amino acid identity with IL-22BP and with the extracellular domain of IL-20R, IL-20Rβ, IL-22R, IL-10Rα ( Figure 1B) .
The expression of the LICR2 gene was analysed by RT-PCR with oligonucleotides located in exons 3 and 5. As shown in Figure 2A , LICR2 expression is ubiquitous, with the strongest expression in breast, colon, liver and testis. Interestingly, a second PCR performed with oligonucleotides located in exons 5 and 7 detected a second smaller band that was expressed at lower level in some tissue samples such as liver ( Figure 2B ). This PCR product was sequenced, and turned out to correspond to an alternative splicing product that lacked exon 6 sequences. Translation of this variant resulted in a shorter protein of 244 amino acids without any transmembrane and cytoplasmic domains (EMBL\GenBank2 accession number AJ534331).
LICR2 cytoplasmic domain activates STAT factors
To address whether LICR2 is capable of transmitting a signal upon activation, we constructed a chimaeric receptor consisting of the extracellular part of the IL-10Rα chain joined to the transmembrane and intracellular parts of LICR2. Upon IL-10 stimulation, this chimaeric receptor should dimerize with IL-10Rβ. As the short cytoplasmic domain of IL-10Rβ recruits the Tyk2 tyrosine kinase, but does not directly activate STAT transcription factors, this chimaeric construct can be used to assess the ability of the cytoplasmic domain of LICR2 to activate STAT factors. HT-29 cells, which express endogenously IL-10Rβ, but not IL-10Rα, were electroporated with the cDNA for the chimaeric receptor and with pGRR5, a luciferase reporter construct regulated by five copies of a STAT-binding sequence recognized at least by STAT1, STAT3 and STAT5. As shown in Figure 3 , IL-10 induced a significant increase of luciferase activity in cells transfected with the chimaeric receptor. Similar results were obtained after transfection of the chimaeric construct in HEK-293 kidney cells and in H4IIE rat hepatoma cells (results not shown). To characterize further which STAT factors are activated by the LICR2 cytoplasmic domain, we performed a Western blot using H4IIE cells transiently transfected with the IL-10R-LICR2 chimaeric receptor. Cells were stimulated with IL-10 or with IL-22 as a positive control. As shown in Figure 4 , activation of the chimaeric receptor resulted in phosphorylation of STAT1, STAT2 and STAT3. A weak, but reproducible, phosphorylation of STAT5 was also observed. No phosphorylation of ERK1\2 was observed upon IL-10 stimulation, in contrast with IL-22 [19] .
STAT activation by LICR2 is JAK1-dependent
As JAKs are known to be responsible for STAT phosphorylation in response to cytokines, we next investigated which JAK is activated by the cytoplasmic domain of LICR2, using 2C4 fibroblasts and their JAK-deficient variants [17, 18] . These cells, which do not express endogenous IL-10Rα [20] , were transfected with the IL-10R-LICR2 chimaeric cDNA, together with pGRR5-luc reporter plasmid. As shown in Figure 5 , IL-10 failed to up-regulate luciferase activity in JAK1-deficient cells unless these cells were transfected with JAK1 cDNA, indicating that STAT activation induced by LICR2 is JAK1-dependent. In contrast, parental cells or JAK2-deficient cells were both able to respond to IL-10 upon IL-10R-LICR2 transfection.
STAT activation by IL-10 homologues through LICR2
In order to assess if LICR2 could be a functional receptor for IL-26, an orphan cytokine of the IL-10 family, we transfected HT-29 cells, which endogenously express IL-22R and IL- 
DISCUSSION
In the present paper, we describe a novel protein that displays the typical genomic organization and structural features of type II cytokine receptors. It shares significant similarity with known members of this receptor family, most notably IL-20R and IL-22BP, and its gene is found in close physical proximity to IL22R on human chromosome 1. The gene encoding the mouse orthologue is located on mouse chromosome 4, also at 25 kb from the mouse IL-22R (results not shown).
We have assessed the signalling capacity of LICR2 by fusing its intracellular domain to the ligand-binding domain of IL-10Rα, which forms a heterodimer with IL-10Rβ upon IL-10 stimulation. IL-10Rβ is known to be associated with Tyk2 tyrosine kinase, but studies on IL-10 and IL-22 signal transduction have shown that its short cytoplasmic domain does not recruit any STAT transcription factor or any adaptor protein for the mitogen-activated protein kinase (MAPK) pathway ( [21] ; D. Lejeune and J.-C. Renauld, unpublished work). Our results demonstrate that the IL-10R-LICR2 chimaeric molecule was able to transduce a signal, and caused phosphorylation of STAT1, STAT2, STAT3 and STAT5, but not of the ERK MAPK. This STAT activation was JAK1-dependent, pointing to JAK1 as the tyrosine kinase associated with LICR2. Activation of STAT1, STAT3 and STAT5 by cytokines is a common feature and has been associated with a wide range of biological activities, including cell-growth regulation and differentiation [22] . In contrast, STAT2 activation has, at present, been restricted to type I IFNs [23, 24] , and our results suggest that LICR2 might be also involved in anti-viral responses.
Because LICR2 is mostly related to IL-20Rα and IL-22BP, it might be a receptor for any known member of the IL-10-related cytokine family. IL-26 (AK155) was an interesting candidate as its receptor has not been characterized at the present time. However, transfection of LICR2 failed to confer responsiveness to IL-26, even in cells expressing most other members of the IL-10R family (IL-10Rβ, IL-20Rα, IL-20Rβ and IL-22R). Similar negative results were obtained by co-transfecting LICR2 and the different IFN receptor chains (results not shown). In addition, polyclonal antibodies generated against the extracellular domain of LICR2 failed to inhibit IL-26 activity on human epithelial cells (results not shown). Taken together, these results strongly suggest that LICR2 is not responsible for IL-26 biological activities. We have also investigated the ability of all IL-10-related cytokines, including IFNs, to activate STAT-3 in LICR2-transfected HEK293 cells, and failed to notice any activation (results not shown). Altogether, these observations suggest that LICR2 binds to a new cytokine, or acts through dimerization with another cytokine receptor chain. The identification of this putative ligand or receptor chain will be a critical step to the further understanding of the biological functions of LICR2.
